Skip to main content
. 2022 Feb 8;10(2):401. doi: 10.3390/biomedicines10020401

Figure 1.

Figure 1

(AD) Correlations between changes in serum lipids and changes in markers for liver function at 3 months after the start of pemafibrate. AST, aspartate aminotransferase; HDL-C, high-density lipoprotein-cholesterol; non-HDL-C, non-high-density lipoprotein-cholesterol; TG, triglyceride.